ArticleJournal of advanced pharmaceutical technology & research2022
Knowledge and awareness about fibrodysplasia ossificans progressiva among dental students.
Article in Journal of advanced pharmaceutical technology & research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder which is autosomal dominant distinguished by congenital malformations of large toes and flare ups, etc. It is a disorder of connective tissue, with heterotopic ossifications seen with skeletal muscles, tendons, and cartilages and also called as Stone man disease, myositis ossificans, and Munchmeyer disease. The main objective of the study is to assess and create the awareness about FOP among dental students. An online-based survey was conducted among 103 dental students, undergraduates and postgraduates. About 20 questionnaires were prepared and circulated among the students through the "Google forms" across Chennai. A survey questionnaire asked about the knowledge of fibrodysplasia, its causes, treatment, and diagnosis was enquired. Thus, the data obtained were analyzed statistically using the SPSS software. In our study, about 64% were undergraduates and 35% of them were postgraduates. About 66% of the participants were aware of fibrodysplasia and 32% of them were not aware. Most of the undergraduate students were more aware of fibrodysplasia (40%) when compared to postgraduates (29%). However, this is statistically not significant. Fibrodysplasia ossificans reported to have a high incidence in 1 in 2 million people worldwide. Hence, an early diagnosis of this disorder can prevent further complications. Although the survey has provided significant knowledge about fibrodysplasia, awareness still has to be created among dental students.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.